Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma? (Q38455324)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209684%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209684%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209684%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Janine M. LaSalle

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209684%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Regina Gandour-Edwards

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209684%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Primo N Lara

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209684%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Ann K Folkins

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209684%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Yueju Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209684%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Frederick J Meyers

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209684%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Ralph DeVere-White

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209684%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 September 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209684%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209684%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209684%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

1009-1015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209684%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209684%20AND%20SRC:MED&resulttype=core&format=json

The role of adjuvant chemotherapy for locally advanced bladder cancer

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

Neo-adjuvant chemotherapy in invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

Progress in the management of metastatic bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

Gemcitabine in locally advanced and/or metastatic bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

Bladder cancer: state-of-the-art care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

7 January 2021

Current management of invasive and metastatic transitional cell carcinoma of the bladder.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

7 January 2021

Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

7 January 2021

An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

7 January 2021

p53 and erbB-2 protein overexpression are associated with early invasion and metastasis in bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

7 January 2021

Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

7 January 2021

Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

7 January 2021

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

7 January 2021

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

7 January 2021

Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10808

7 January 2021

Identifiers

DOI

10.1002/CNCR.10808

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209684%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209684%20AND%20SRC:MED&resulttype=core&format=json